PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

Clinical trial NCT03655236 · TERMINATED

Trial details

NCT number: NCT03655236
Sponsor: Sun Pharma Advanced Research Company Limited
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Early Parkinson Disease

Start date: 2019-02-18
Primary completion: 2024-04-08
Enrollment: 513

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.